medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2025, Número 1

<< Anterior Siguiente >>

Rev Biomed 2025; 36 (1)


Comportamiento de sobrepeso-obesidad con parámetros bioquímicos antes y durante la pandemia COVID-19 en jóvenes universitarios

Trejo-Sánchez BE, Sánchez-Barragan B, Romero-Vázquez A, González-Garrido JA

Idioma: Español
Referencias bibliográficas: 35
Paginas: 4-12
Archivo PDF: 133.97 Kb.


RESUMEN

Introducción. La obesidad es un factor de riesgo en el desarrollo de complicaciones graves por SARSCoV- 2, al igual que en enfermedades crónicas como la diabetes mellitus tipo 2 y la hipertensión. Sin embargo, el único padecimiento que puede revertirse es la obesidad, disminuyendo la inflamación y fortaleciendo el sistema inmune.
Objetivo. Conocer el comportamiento de sobrepeso-obesidad con parámetros bioquímicos antes y durante la pandemia COVID-19 en jóvenes universitarios.
Material y métodos. Se realizó un estudio observacional transversal analítico con datos de antes de la pandemia (2015-2017) y durante la pandemia (2021) de estudiantes universitarios (n= 5886) con edad promedio de 18 años, del Campus Chontalpa de la Universidad Juárez Autónoma de Tabasco. El IMC se calculó con base en los criterios establecidos por la OMS.
Resultados. En pandemia, se incrementó la prevalencia de sobrepeso-obesidad (7.10% en hombres y 5.50% en mujeres) y la de su CA (14.40% en hombres y 4.30% en mujeres) con una fuerte correlación (p valor < 0.01) en ambos periodos y sexos. Se observó un mayor incremento en las mujeres durante la pandemia en comparación con los hombres, respecto a los resultados prepandemia. La prevalencia de valores de riesgos de glucosa fue 30.17%, de triglicéridos del 37.48% y de colesterol del 21.46% en ambos periodos.
Conclusión. El comportamiento de la prevalencia de sobrepeso-obesidad incrementó, lo que indica un aumento del riesgo metabólico durante la pandemia en comparación con el periodo prepandemia.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Katsiki N, Gómez-Huelgas R, Mikhailidis DP, Pérez-Martínez P. Narrative review on clinical considerationsfor patients with diabetes and COVID-19: Morequestions than answers. Int J Clin Pract 2021:75. https://doi.org/10.1111/ijcp.14833.

  2. Terruzzi M, Ferrulli A, Capra ME, Stanyevic B, GiudiceA, Monopoli D, et al. The Effects of COVID-19Pandemic and Lockdown on Pediatric Nutritional andMetabolic Diseases: A Narrative Review 2022. https://doi.org/10.3390/nu15010088.

  3. Fainardi V, Meoli A, Chiopris G, Motta M, SkenderajK, Grandinetti R, et al. Long COVID in Children andAdolescents 2022. https://doi.org/10.3390/life12020285.

  4. López-Moreno M, Iglesias López MT, Miguel M,Garcés-Rimón M. Physical and Psychological EffectsRelated to Food Habits and Lifestyle Changes Derivedfrom COVID-19 Home Confinement in the SpanishPopulation 2020. https://doi.org/10.3390/nu12113445.

  5. Bovolini A, Garcia J, Andrade MA, Duarte JA.Metabolic Syndrome Pathophysiology and PredisposingFactors. Int J Sports Med 2021;42:199–214. https://doi.org/10.1055/A-1263-0898/ID/R8170-0017/BIB.

  6. León-Pedroza JI, Rodríguez-Cortés O, Flores-MejíaR, Gaona-Aguas CV, González-Chávez A. Impact ofMetabolic Syndrome in the Clinical Outcome of Diseaseby SARS-COV-2. Arch Med Res 2021;52:738–45.https://doi.org/10.1016/J.ARCMED.2021.04.001.

  7. Bojkova D, Costa R, Reus P, Bechtel M, Jaboreck MC,Olmer R, et al. Targeting the pentose phosphate pathwayfor sars-cov-2 therapy. Metabolites 2021;11. https://doi.org/10.3390/METABO11100699/S1.

  8. Pérez-Torres I, Soto ME, Guarner-Lans V, Manzano-Pech L, Soria-Castro E. The Possible Role of Glucose-6-Phosphate Dehydrogenase in the SARS-CoV-2 Infection.Cells 2022;11. https://doi.org/10.3390/CELLS11131982.

  9. Nachimuthu S, Vijayalakshmi R, Sudha M, ViswanathanV. Coping with diabetes during the COVID – 19lockdown in India: Results of an online pilot survey.Diabetes and Metabolic Syndrome: Clinical Researchand Reviews 2020;14:579–82. https://doi.org/10.1016/J.DSX.2020.04.053.

  10. Belén Ruiz-Roso M, Knott-Torcal C, Matilla-EscalanteDC, Garcimartín A, Sampedro-Nuñez MA, DávalosA, et al. COVID-19 Lockdown and Changes of theDietary Pattern and Physical Activity Habits in a Cohortof Patients with Type 2 Diabetes Mellitus. Nutrients2020;12:1–16. https://doi.org/10.3390/nu12082327.

  11. Muscogiuri G, Barrea L, Savastano S, Colao A.Nutritional recommendations for CoVID-19 quarantine.Eur J Clin Nutr 2020;74:850–1. https://doi.org/10.1038/s41430-020-0635-2.

  12. Nopp S, Moik F, Klok FA, Gattinger D, Petrovic M,Vonbank K, et al. Outpatient Pulmonary Rehabilitationin Patients with Long COVID Improves ExerciseCapacity, Functional Status, Dyspnea, Fatigue, andQuality of Life. Respiration 2022;101:593. https://doi.org/10.1159/000522118.

  13. Alberti KGMM, Zimmet P, Shaw J. The metabolicsyndrome - A new worldwide definition. Lancet2005;366:1059–62. https://doi.org/10.1016/S0140-6736(05)67402-8.

  14. Grundy SM, Cleeman JI, Daniels SR, DonatoKA, Eckel RH, Franklin BA, et al. Diagnosis andManagement of the Metabolic Syndrome. Circulation2005;112:2735–52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404.

  15. Murthy H, Iqbal M, Chavez JC, Kharfan-Dabaja MA.Cytokine Release Syndrome: Current Perspectives.Immunotargets Ther 2019;8:43. https://doi.org/10.2147/ITT.S202015.

  16. Kawai T, Autieri M V., Scalia R. Inflammation: FromCellular Mechanisms to Immune Cell Education:Adipose tissue inflammation and metabolic dysfunctionin obesity. Am J Physiol Cell Physiol 2021;320:C375.https://doi.org/10.1152/AJPCELL.00379.2020.

  17. Palacios Ovalle DL, Rodrigo-Cano S, González A, SolerC, Catalá-Gregori AI, Merino-Torres JF, et al. COVIDObesity: A One-Year Narrative Review. Nutrients 2021.https://doi.org/10.3390/nu13062060.

  18. Brambilla I, Delle Cave F, Guarracino C, De FilippoM, Votto M, Licari A, et al. Obesity and COVID-19in children and adolescents: a double pandemic. ActaBiomed 2022;93:2022195. https://doi.org/10.23750/abm.v93iS3.13075.

  19. Instituto Nacional de Salud Pública. Encuesta Nacionalde Salud y Nutricion Continua 2021. 2021.

  20. Yang S, Guo B, Ao L, Yang C, Zhang L, Zhou J, etal. Obesity and activity patterns before and duringCOVID‐19 lockdown among youths in China. Clin Obes2020;10. https://doi.org/10.1111/COB.12416.

  21. Park HK, Lim JS. Change of obesity prevalenceand lifestyle patterns before and during COVID-19among Korean adolescents. Ann Pediatr EndocrinolMetab 2022;27:183. https://doi.org/10.6065/APEM.2244116.058.

  22. Rúa-Alonso M, Rial-Vázquez J, Nine I, Lete-Lasa JR,Clavel I, Giráldez-García MA, et al. Comparison ofPhysical Fitness Profiles Obtained before and duringCOVID-19 Pandemic in Two Independent LargeSamples of Children and Adolescents: DAFIS Project.Int J Environ Res Public Health 2022;19:3963. https://doi.org/10.3390/IJERPH19073963/S1.

  23. Von Hippel PT, Workman J. From Kindergarten ThroughSecond Grade, U.S. Children’s Obesity PrevalenceGrows Only During Summer Vacations. Obesity2016;24:2296–300. https://doi.org/10.1002/oby.21613.

  24. Getahun MS, Deybasso HA, Komicha MA, Gurara AM.Magnitude of central obesity and associated factorsamong adult patients attending public health facilities inAdama town, Oromia region, Ethiopia, 2022. J HealthPopul Nutr 2023;42. https://doi.org/10.1186/s41043-023-00397-z.

  25. Hosp N, Parra-Rojas I, Domínguez-Reyes T, Quiroz-Vargas I, Berenice Salgado-Bernabé A, Salgado-Goytia L, et al. Nutrición Hospitalaria Trabajo OriginalObesidad y síndrome metabólico Correspondencia:Anthropometric measurements as predictive indicatorsof metabolic risk in a Mexican population n.d. https://doi.org/10.20960/nh.983.

  26. Charlotte Steenblock A, Hassanein M, Khan EG, YamanM, Kamel M, Barbir M, et al. Review Obesity andCOVID-19: What are the Consequences? BibliographyHorm Metab Res 2022;54:496–502. https://doi.org/10.1055/a-1878-9757.

  27. Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes ashigh‐risk factors for severe coronavirus disease 2019(Covid‐19). Diabetes Metab Res Rev 2021;37. https://doi.org/10.1002/DMRR.3377.

  28. Lacavalerie MR, Pierre-Francois S, Agossou M, InamoJ, Cabie A, Barnay JL, et al. Obese patients with longCOVID-19 display abnormal hyperventilatory responseand impaired gas exchange at peak exercise. FutureCardiol 2022;18:577–84. https://doi.org/10.2217/FCA-2022-0017.

  29. Park HJ, Jung JH, Han K, Shin J, Lee Y, Chang Y, et al.Association between metabolic syndrome and mortalityin patients with COVID-19: A nationwide cohort study.Obes Res Clin Pract 2022;16:484–90. https://doi.org/10.1016/J.ORCP.2022.10.011.

  30. Aghili SMM, Ebrahimpur M, Arjmand B, Shadman Z,Pejman Sani M, Qorbani M, et al. Obesity in COVID-19era, implications for mechanisms, comorbidities, andprognosis: a review and meta-analysis. Int J Obes(Lond) 2021;45:998. https://doi.org/10.1038/S41366-021-00776-8.

  31. Escobedo J, Schargrodsky H, Champagne B, SilvaH, Boissonnet CP, Vinueza R, et al. Prevalence of theMetabolic Syndrome in Latin America and its associationwith sub-clinical carotid atherosclerosis: the CARMELAcross sectional study. Cardiovasc Diabetol 2009;8:52.https://doi.org/10.1186/1475-2840-8-52.

  32. Pérez-Castro E, Godínez-Jaimes F, Uriel Vázquez-Medina M, Ocharan-Hernández ME, Vargas-De-LeónC. Derivation and validation of sex-specific continuousmetabolic syndrome scores for the Mexican adultpopulation. Scientific Reports | 123AD;12:9659. https://doi.org/10.1038/s41598-022-10963-w.

  33. Jeon WH, Seon JY, Park SY, Oh IH. Association ofMetabolic Syndrome with COVID-19 in the Republicof Korea. Diabetes Metab J 2021;46:427–38. https://doi.org/10.4093/DMJ.2021.0105.

  34. Xi B, Cadenas-Sanchez C. Editorial: Metabolicallyhealthy and unhealthy obese children andadolescents, volume II 2022. https://doi.org/10.3389/fendo.2022.1111060.

  35. Tsatsoulis A, Paschou SA. Metabolically HealthyObesity: Criteria, Epidemiology, Controversies, andConsequences. Curr Obes Rep 2020;9:109–20. https://doi.org/10.1007/S13679-020-00375-0.




2020     |     www.medigraphic.com